Teva Prevails in ANDA Litigation

July 2023

Williams & Connolly client Teva Pharmaceuticals prevailed in patent litigation involving Teva's product Qvar®, a steroid inhaler treatment for asthma.  In July 2023, following a bench trial before the U.S. District Court for the District of New Jersey in which Williams & Connolly served as lead trial counsel, the court issued a thorough decision ruling for Teva on every issue. 
The team representing Teva included partners David Berl, Ben Greenblum, and Elise Baumgarten and associates Kat Kayali, Ben Picozzi, and Ricardo Leyva

The American Lawyer Litigation Daily named the Williams & Connolly’s team representing Teva Pharmaceuticals “Litigators of the Week Runners-Up.” 

Click here to read Litigation Daily’s “Litigator of the Week.”

back to top